Clinical Trial Update: A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and changes in sAg levels in chronic hepatitis B patients treated with clevudine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 4 | Status: TERMINATED